Search Results - "Nataraj, KS"

Refine Results
  1. 1

    Plasmablastic Myeloma- A Diagnostic Dilemma by Shiva Kumar Komaravelli, MB Deepak, S Bharath Ram, Hamza Dalal, KS Nataraj

    “…Plasmablastic neoplasms comprise various haematolymphoid tumours with plasmablastic morphology which includes Plasmablastic Myeloma (PBM) and Plasmablastic…”
    Get full text
    Journal Article
  2. 2

    Plasmablastic MyelomaA Diagnostic Dilemma by Komaravelli, Shiva Kumar, Deepak, MB, Ram, S Bharath, Dalal, Hamza, Nataraj, KS

    “…Plasmablastic neoplasms comprise various haematolymphoid tumours with plasmablastic morphology which includes Plasmablastic Myeloma (PBM) and Plasmablastic…”
    Get full text
    Journal Article
  3. 3

    Higher Than Reported Response Rates to Decitabine Observed in Indian AML Patients - Is There a Genomic Basis by Damodar, Sharat, Nataraj, KS, Niveditha, SR, Purnaiya, Rajeev, Kumar, Madan, Nagaraj, Ashwin, Ram, Prahlad

    Published in Blood (06-12-2014)
    “…Between May 2012 and May 2014, 15 elderly patients (median 64yrs, range 54-80yrs) who presented with acute myeloid leukemia (AML) with comorbidities preventing…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Primary gastrointestinal mucormycosis in an immunocompetent person by Shiva, Prasad BN, Shenoy, A, Nataraj, KS

    Published in Journal of postgraduate medicine (01-07-2008)
    “…In the past decade, mucormycosis has emerged as an important lethal infection in diabetics and other immunocompromised hosts. Rhinosinusitis, pansinusitis,…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Hydroxypropyl Methylcellulose Based Cephalexin Extended Release Tablets: Influence of Tablet Formulation, Hardness and Storage on in Vitro Release Kinetics by Saravanan, Muniyandy, Nataraj, Kalakonda Sri, Ganesh, Kettavarampalayam Swaminath

    “…The object of this study was to develop hydroxypropyl methylcellulose (HPMC) based cephalexin extended release tablet, which can release the drug for six hours…”
    Get full text
    Journal Article
  9. 9

    The Effect of Tablet Formulation and Hardness on in Vitro Release of Cephalexin from Eudragit L100 Based Extended Release Tablets by Saravanan, Muniyandy, Nataraj, Kalakonda Sri, Ganesh, Kettavarampalayam Swaminath

    Published in Biological & pharmaceutical bulletin (01-04-2002)
    “…Eighteen batches of cephalexin extended release tablet were prepared by wet granulation method by using Eudragit L100. The effect of the concentration of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Prevalence of Genetic Abnormalities in Patients with Multiple Myeloma and Its Clinical Relevance in a Developing Country like India by Shah, Aditi, KS, Nataraj, T S, Sundareshan, Prabhu, Shilpa, RAM S, Bharath, Dalal, Hamza Yusuf, Komaravelli, Shiva Kumar, Damodar, Sharat

    Published in Blood (05-11-2020)
    “…Introduction Multiple myeloma (MM) is a malignancy involving terminally differentiated plasma cells. Its incidence in India is about 0.7/1,00,000 population…”
    Get full text
    Journal Article
  12. 12

    Minimal Residual Disease (MRD) Assessment after Induction Chemotherapy in Children and Adults with Acute Lymphoblastic Leukemia (ALL): A Valuable Strategy in Resource Constraint Settings in the Indian Subcontinent by kUMAR, Karuna, Sinha, Swasti, Annapandian, Vellaichamy, KS, Nataraj, Badiger, Shoba, Bhat, Sunil, Damodar, Sharat

    Published in Blood (08-12-2017)
    “…Background: In a developing country with limited resources and insurance coverage, it is very important to risk stratify patients early in the treatment of…”
    Get full text
    Journal Article
  13. 13

    Day 5 Peripheral Blood Blasts and Day 14 Bone Marrow Studies As Predictors for Response to Therapy in Acute Myeloid Leukemia (AML): An Experience from Indian Subcontinent by Prabhu, Shilpa, KS, Nataraj, Damodar, Sharat, Sinha, Swasti, Bhat, Sunil, Badiger, Shoba, Annapandian, Vellaichamy

    Published in Blood (08-12-2017)
    “…Day 5 Peripheral Blood Blasts and Day 14 Bone Marrow Studies as Predictors for Response to Therapy in Acute Myeloid Leukemia (AML): An Experience from Indian…”
    Get full text
    Journal Article
  14. 14

    ANALYTICAL QUALITY BY DESIGN APPROACH IN RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF DUVELISIB by CH, SRUJANI, P, ANNAPURNA, KS, NATARAJ, MANJARI PAWAR A, KRISHNA

    “…Objective: A simple, accurate, and robust RP-HPLC method was developed and validated for the estimation of Duvelisib using analytical quality by design…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20